Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia

Aim: There is an unmet need in Japan for more optimal lipid-lowering therapy (LLT) for patients with homozygous familial hypercholesterolemia (HoFH) who respond inadequately to available drug therapies and/or apheresis, to achieve goals of low-density lipoprotein cholesterol (LDL-C) reduction by 50%...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Atheroscler Thromb
Main Authors: Harada-Shiba, Mariko, Ikewaki, Katsunori, Nohara, Atsushi, Otsubo, Yoshihiko, Yanagi, Koji, Yoshida, Masayuki, Chang, Qing, Foulds, Pamela
Formato: Artigo
Idioma:Inglês
Publicado em: Japan Atherosclerosis Society 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5392478/
https://ncbi.nlm.nih.gov/pubmed/28154305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.38216
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados